Ece Genç

Prof. Ece Genç is a distinguished academic at Yeditepe University's Faculty of Medicine, Department of Clinical Pharmacology. With a career spanning over four decades, she has held faculty positions at Istanbul University (1974-2004) and visiting roles at institutions like the National Institutes of Health (1989) and University of California, Irvine (1982).

• Education:
  • B.Sc. in Chemical Engineering, Boğaziçi University (1973)
  • Ph.D. in Pharmacology, Istanbul University (1977)

Her research focuses on neuropharmacology, genetic influences on drug response, and metabolic-neurological interactions. Key areas include opioid-dopamine-GABA pathways, statin therapy variability, and genetic risk factors for sleep apnea and obesity. Her work bridges clinical pharmacology, neuroscience, and genetics through animal models and population studies.

Her recent publications analyze warfarin dosing (2019), obesity genetics (2017-2018), and oxidative stress in diabetes (2010). These studies span SCI/SSCI journals, emphasizing pharmacogenomics and translational research.

Scientific Awards:

• Service Award, Istanbul University (for 40+ years in pharmacology)
• Contributions to Turkish Pharmacology Association

Prof. Genç has supervised 5+ theses, led 3+ grants (e.g., TÜBİTAK 1003 project), and authored 4+ books. She served as Head of Clinical Pharmacology at Yeditepe University (2005) and collaborated with Max-Planck Institute (1979).